Before and After TMS: Tracking Real Progress
- Sophroneo Psychiatry
- Jun 8
- 4 min read
TMS improvement can be hard to notice while it is happening. A person may sit through session after session, feel only a tapping sensation on the scalp, and wonder whether anything is changing. Then, several weeks later, they may realize sleep is steadier, work feels less impossible, or a depression score has dropped enough to matter.
That is why TMS progress tracking matters. It turns a gradual brain-based treatment into something visible. Instead of relying only on memory or mood from one difficult day, you can measure symptoms and function across the full course of care.
This article is educational and is not a substitute for diagnosis, treatment advice, or a personalized TMS plan. If your depression includes thoughts of suicide, self-harm, or feeling unable to stay safe, call or text 988 in the U.S. or go to the nearest emergency department.
If you are considering care, start with Sophroneo Behavioral Health & TMS and the clinic's overview of NeuroStar TMS. Tracking works best when it is part of a real treatment plan, not a self-diagnosis exercise.
What standardized scores actually measure
The PHQ-9 and GAD-7 are short questionnaires that help clinicians track depression and anxiety symptoms over time. They are not perfect, but they are useful because they ask the same questions in the same way each time. That consistency helps separate true change from a single good or bad day.
The PHQ-9 measures depressive symptoms such as low mood, loss of interest, fatigue, sleep disruption, appetite change, concentration problems, guilt, slowed movement, and thoughts of self-harm. The GAD-7 measures anxiety symptoms such as worry, restlessness, irritability, tension, and fear that something bad may happen.
If you are still learning the basics, Sophroneo's pages on depression treatment and anxiety treatment explain how these symptoms may show up in care.
Why your own perception is not always enough
Depression can distort self-assessment. A bad night of sleep can make progress feel fake. A stressful week can make it seem like treatment is failing even when scores are improving. Anxiety can do the same thing by pulling attention toward threat and away from evidence of change.
Tracking creates an anchor. If your PHQ-9 score moves from 19 to 14 and then to 10, you have information your memory may not give you. If your sleep improves before mood does, that may still be an early sign that the nervous system is responding.
For more context on how TMS changes can unfold across time, Sophroneo's article on what to expect during an accelerated TMS week and the guide to depression symptoms, antidepressants, and TMS are useful companion reads.
How to build a simple TMS tracking log
You do not need a complicated system. You need consistency. Before session one, record your baseline. Then update your log weekly, preferably on the same day and at roughly the same time.
Track these basics:
• PHQ-9 total score.
• GAD-7 total score, if anxiety is part of the picture.
• Sleep hours and sleep quality.
• Work, school, or task follow-through.
• Social engagement or avoidance.
• Medication changes or major life stressors.
• One short note about how the week actually felt.
Do not score yourself every hour. More data is not always better. Daily scoring can create noise, especially when the tools ask about symptoms over the past two weeks. Weekly review is often enough to show a trajectory.
How Sophroneo uses progress tracking in care
At Sophroneo, tracking is not just paperwork. It helps the treatment team see whether TMS is moving symptoms, whether anxiety and depression are changing together, whether sleep is improving, and whether the plan needs adjustment.
A good progress review may ask: Are scores moving down? Is function improving? Did symptoms plateau? Are side effects tolerable? Is the diagnosis still accurate? Would medication management, therapy, maintenance TMS, or another service improve the plan?
The broader Sophroneo services menu, the page on how TMS works, and the guide to whether TMS may be right for you can help you understand what those next-step conversations may include.
A short TMS explainer before you track outcomes
The video below gives a medical overview of brain stimulation treatments, including TMS. It can help you understand why changes may build gradually rather than appear immediately after the first session.
What to do with partial improvement
Not everyone reaches full remission after a standard course. That does not automatically mean TMS failed. A meaningful score reduction can still reduce suffering and improve function. The question is what the data shows and what the next clinical step should be.
If scores are still improving near the end of treatment, an extended course or maintenance plan may be considered. If scores plateau, the provider may revisit diagnosis, protocol, medication, sleep, anxiety, trauma symptoms, or another treatment option. If you want a broader comparison, Sophroneo's TMS vs. Spravato, ketamine, and ECT guide can help frame the discussion.
Frequently asked questions
What is the PHQ-9?
The PHQ-9 is a nine-question depression scale used in many clinical settings. It helps measure symptom severity and track whether depression is improving over time.
How often should I complete the PHQ-9 or GAD-7 during TMS?
Weekly scoring is a practical rhythm for many patients. It is frequent enough to show movement but not so frequent that every daily mood swing becomes the story.
What if my score improves but I do not feel better yet?
That can happen. Scores may shift before the change feels obvious in daily life. Track function, sleep, and energy alongside symptoms so you can see the full picture.
What if I feel better but my score barely changes?
Bring that to your provider. It may mean the score is missing a functional improvement, or it may mean the improvement is real but still fragile. Both possibilities are useful clinical information.
Should I bring my log to appointments?
Yes. A simple log gives your provider better information about trajectory, timing, medication changes, and daily-life impact. It can make the post-treatment review much more useful.
Comments